Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Xeris Biopharma Holdings, Inc. (XERS) director John Johnson engaged in multiple stock transactions on June 4, 2026, involving both sales and acquisitions. The sale was executed under a pre-arranged Rule 10b5-1 trading plan, while the acquisitions consisted of restricted stock units and stock options granted under the company’s 2018 Stock Option and…
Entities linked to Silver Lake and a Dell Technologies director sold $35.7 million in Class C Common Stock on June 3, 2026, as the stock trades near multi-year highs. The sales occur against a backdrop of robust first-quarter fiscal 2027 results and upgraded analyst price targets, yet valuation metrics suggest the stock may be overextended.
Silver Lake Technology Investors V, L.P., an affiliate of Silver Lake Group, L.L.C., along with entities affiliated with Dell Technologies Inc. (NYSE:DELL) director Egon Durban, executed a sale of 609 shares of Dell's Class C Common Stock on June 3, 2026. The transaction, valued at $257,591, occurred at prices between $420.22 and $430.07 per share.…
Luis Miguel Palomino Bonilla, a director at Southern Copper Corp (NYSE:SCCO), disposed of 4 shares of the company's common stock on June 5, 2026, according to a U.S. Securities and Exchange Commission filing. The transaction occurred at $181.0 per share, resulting in $724 in total proceeds. This sale follows a period of significant corporate change…
Dawn Halkuff, a director at Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), executed a sale of 20,000 shares on June 4, 2026, valued at $121,885. The transaction, conducted under a pre-established Rule 10b5-1 trading plan, was accompanied by the receipt of restricted stock units and stock options. This activity follows the company's reported first-qu…
Barbara-Jean Anne Bormann-Kennedy, a director at Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), executed a series of equity transactions on June 4, 2026. The activity includes the sale of 16,000 shares through a pre-arranged trading plan, as well as the acquisition of restricted stock units and stock options granted by the company. These transaction…
Silver Lake and Dell Technologies director Egon Durban executed a sale of 35,437 Class C Common Stock shares on June 3, 2026, realizing approximately $14.99 million. The sales, priced between $420.22 and $430.07 per share, occurred after a period of substantial stock appreciation and concurrent analyst optimism regarding Dell's performance in the A…
An investment vehicle tied to Dell Technologies Inc. (NASDAQ: DELL) director Egon Durban has fully liquidated its position in the company's Class C Common Stock, realizing approximately $571,444 in proceeds. The transaction marks the final exit of Silver Lake Technology Investors IV, L.P. from the direct Class C share registry, occurring against a …
Kyle Sauers, Chief Financial Officer and President of Rush Street Interactive, Inc. (NASDAQ: RSI), executed a sale of 23,000 shares of the company’s Class A Common Stock on June 3, 2026. The transaction, valued at $585,120, was conducted at $25.44 per share and falls under a pre-arranged 10b5-1 plan. Following the sale, Sauers retains direct owners…
Diane Elizabeth Hare, a director at Nano Nuclear Energy Inc. (NASDAQ:NNE), executed a complete divestiture of her company holdings on June 3, 2026. The transaction involved the sale of 3,428 shares immediately following the vesting of restricted stock units, resulting in zero direct ownership of the company's common stock. The sales were conducted …
Jones Christy, a director at Beta Bionics, Inc. (NASDAQ:BBNX), executed a sale of 2,811 shares on June 4, 2026, valued at $39,354. The transaction was conducted under a Rule 10b5-1 Plan established on February 19, 2026. Post-transaction, Christy retains direct ownership of 27,400 shares. The sale occurs amidst mixed analyst sentiment following the …
MiNK Therapeutics, Inc. (NASDAQ: INKT) director Barbara Ryan completed the sale of 1,500 shares of common stock on June 4, 2026. The transaction, executed through two direct sales, generated proceeds of $19,141 at share prices between $12.6835 and $12.7995. These shares were originally granted as compensation for her board service. Following the sa…
Mark Hopman, the Chief Commercial Officer of Beta Bionics, Inc. (NASDAQ:BBNX), executed a sale of 275 common shares on June 4, 2026. The transaction, valued at $3,385, was conducted at a per-share price of $12.31. This sale follows the terms of a Rule 10b5-1 trading plan established on May 13, 2025. Post-transaction, Hopman retains a direct stake o…
Antonio J Viana, a director at Arteris, Inc. (NASDAQ:AIP), executed a sale of company common stock valued at $760,879 on June 4, 2026. The transaction involved the disposal of 20,839 shares, priced between $35.4661 and $37.089 per share, conducted indirectly through the Viana Family Trust. This sale follows a 348% return over the past year and occu…
Renee Gaeta, the Chief Financial Officer of Outset Medical, Inc. (NASDAQ: OM), completed a stock transaction on June 3, 2026, selling 17,672 shares for a total value of $87,299. The transaction, executed at a price of $4.94 per share, was designated as a "sell to cover" event intended to satisfy tax withholding requirements. This activity coincides…
Jay A. Bys, Executive Vice President and Chief Commercial Officer at California Resources Corp, executed a pre-arranged sale of company stock valued at approximately $734,423. The transaction, conducted under a Rule 10b5-1 trading plan, occurs as the energy company reports mixed financial results for the first quarter of 2026 and advances its carbo…
Kenda B. Gonzales, a director at PERDOCEO EDUCATION Corp (NASDAQ:PRDO), executed a simultaneous exercise and sale of 9,308 common stock shares on June 4, 2026. The transaction, valued at $323,825, followed the acquisition of the same number of shares via non-qualified options. This activity occurred against a backdrop of reported strong first-quart…
Peter Graham, a member of the board of directors at Onterris, Inc. (NASDAQ:ONT), executed a direct purchase of company equity on June 3, 2026. This transaction reflects a strategic accumulation of shares by an insider as the stock experiences a notable decline over the preceding six-month period. The acquisition brings Mr. Graham's direct holding t…
James John Walker, Chief Executive Officer of Nano Nuclear Energy Inc. (NASDAQ: NNE), executed a series of transactions on June 3, 2026, disposing of approximately $3.28 million in company shares. The sales were conducted under a Rule 10b5-1 trading plan, a mechanism designed to facilitate pre-arranged stock transactions. Concurrently, Mr. Walker a…
Kristen Williams, Chief Administrative Officer at Pacira BioSciences, Inc., has completed a series of stock dispositions totaling over $418,000, according to recent Securities and Exchange Commission filings. The transactions include both voluntary sales under a Rule 10b5-1 plan and involuntary withholdings for tax obligations. These moves come as …
Kodiak Sciences Inc. (NASDAQ:KOD) Chief Financial Officer John A. Borgeson sold 30,000 shares of the company's common stock on June 4, 2026, generating $1,023,008 in proceeds. The sales were executed through a 10b5-1 trading plan established on September 29, 2025. Prior to the sale, Borgeson exercised 30,000 options at $1.04 per share, totaling $31…
Bernard Shek, serving as the Chief Legal Officer and Secretary for SanDisk Corp (NASDAQ:SNDK), completed a significant stock sale on June 3, 2026. The transaction involved the liquidation of 600 shares, generating proceeds totaling $1,041,600. This sale was executed at a price of $1,736.0 per share. The transaction was carried out in accordance wit…
Seth Jason Berl, a director at Nano Nuclear Energy Inc. (NASDAQ:NNE), executed a sale of 3,750 shares on June 5, 2026, totaling $93,458. This transaction follows a recent period of stock depreciation and occurs alongside significant corporate developments, including regulatory approvals and strategic acquisitions aimed at expanding the company's op…
Michael Wittmann, Chief Operating Officer at indie Semiconductor, Inc., executed a sale of 39,645 Class A Common Stock shares on June 4, 2026, generating proceeds of $190,446. The transaction, conducted at prices between $4.80 and $4.825 per share, reduces Wittmann's direct holding to 98,309 shares. This sale follows a period of significant stock d…
Celso L Jr., Executive Vice President and Chief Financial Officer of Cleveland-Cliffs Inc. (CLF), executed a sale of 214,308 common shares on June 5, 2026, totaling $2,874,641. The transaction, conducted at prices between $13.355 and $13.48 per share, leaves Mr. Goncalves with a direct holding of 184,541.613 shares. This sale occurs against a backd…
